All Studies

Neuroprotective effects of Gypenosides: A review on preclinical studies in neuropsychiatric disorders.

Gynostemma pentaphyllum gypenosides show promise in treating neuropsychiatric disorders. More research needed for clinical applications. Important for potential neuroprotective properties and improving human health.

Liang G et al (2024).
Eur J Pharmacol.
PubMed:
38908668

Sugarcane (Saccharum officinarum L.) induces psychostimulant, anxiolytic-like effects and improvement of motor performance in rats.

Sugarcane is traditionally used as a tonic and fatigue-fighting remedy. Preclinical studies in rats show that sugarcane leaf extract affects the central nervous and cardiovascular systems through dopaminergic pathways, potentially improving motor, emotional, and cognitive functions.

Ziroldo JC, Torres LMB and Gamberini MT (2024).
J Ethnopharmacol.
PubMed:
38908491

Targeted discovery of unusual diterpenoids with anti-fungal activity from the root of Euphorbia lathyris.

New compounds isolated from E. lathyris show potential as anti-fungal agents. Compound 2 is particularly effective against plant pathogens, offering a promising lead for further research in plant disease control.

Wang Y et al (2024).
Phytochemistry.
PubMed:
38908463

Exploring the safety of cannabidiol (CBD): A comprehensive in vitro evaluation of the genotoxic and mutagenic potential of a CBD isolate and extract from Cannabis sativa L.

Štern A et al (2024).
Biomed Pharmacother.
PubMed:
38908200